MedTrace Logo

Electrostimulation Study for Ocular Graft vs. Host Disease

NCT07166848 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2025-12-17

No results posted yet for this study

Summary

This trial is testing to see if electrostimulation treatment (ET) will be effective in treating those with ocular Graft vs. Host Disease.

Conditions

  • Chronic Ocular Graft-versus-host Disease

Interventions

DEVICE

Electrodes with Currents

Electrodes will be placed on the cheeks and forehead, and treated with an amplitude of 300 µA for 30 mins

DEVICE

Electrodes without Currents

Electrodes will be placed on the cheeks and forehead, and treated with an no amplitude for 30 mins

Sponsors & Collaborators

  • Zhonghui K. Luo, MD, PhD

    lead OTHER

Principal Investigators

  • Zhonghui Luo, MD, PhD · Massachusetts Eye and Ear Infirmary

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-11-30
Primary Completion
2028-11-30
Completion
2029-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07166848 on ClinicalTrials.gov